Redline, Susan http://orcid.org/0000-0002-6585-1610
Azarbarzin, Ali
Peker, Yüksel http://orcid.org/0000-0001-9067-6538
Article History
Accepted: 2 February 2023
First Online: 10 March 2023
Competing interests
: S.R. reports receipt of consulting funds from Apnimed, Eli Lilly and Jazz Pharm. A.A. receives grant support from Somnifix and serves as a consultant for Apnimed, Eli Lilly, Respicardia and Somnifix. A.A.’s interests were reviewed by Brigham and Women’s Hospital and Mass General Brigham in accordance with their institutional policies. Y.P. receives grant support from ResMed Foundation. Apnimed and Eli Lilly are developing pharmacological treatments for obstructive sleep apnoea, and ResMed produces devices for the treatment of sleep apnoea.